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critical role in cell differentiation and morphogenesis of the
thyroid gland and the lung.1 Antibodies to TTF-1 are widely
used in clinical practice for tumors originating from either
the thyroid or lung. Primary nasopharyngeal papillary
adenocarcinoma is microscopically similar to thyroid papil-
lary adenocarcinoma and an immunohistochemical stain with
thyroglobulin antibody is typically used to distinguish be-
tween these two diseases.2 In addition to thyroglobulin, an
immunohistochemical stain for TTF-1 could be helpful. To
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http://dx.doi.org/10.1016/j.jfma.2013.04.012with the TTF-1 antibody in one primary nasopharyngeal
papillary adenocarcinoma.
A 36-year-old woman presented with right epistaxis and
persistent nasal obstruction with a duration of 3 months.
The physical examination revealed a pedunculated tumor
at the roof of the nasopharynx. No other physical abnor-
malities were found. Complete excision of the tumor was
performed through an endoscope. The pathology study
revealed an adenocarcinoma with papillary structure and
focal glandular formation. The cancer cells were non-
immunoreactive to thyroglobulin, but expressed strong
nuclear staining of TTF-1 (Fig. 1). Postoperatively, positron
emission tomography did not show any abnormal uptake of
18F-fludeoxyglucose in the nasopharynx, thyroid gland, or
other parts of the body. No postoperative adjuvant treat-
ment was given. The patient has not experienced any& Formosan Medical Association. All rights reserved.
Figure 1 Immunohistochemical reactivity shows strong
nuclear staining for thyroid transcription factor-1 (TTF-1)
protein (original magnification, 66; Avidin-biotin complex
(ABC) method).
474 C.-H. Huang et al.locoregional recurrence or distant metastasis to date (31
months postoperation).
Papillary adenocarcinoma of the nasopharynx can be
metastasized from the thyroid gland and the lung, or pri-
marily originates from the nasopharynx. Because primary
nasopharyngeal papillary adenocarcinoma is extremely rare,
it is necessary to exclude nasopharyngeal metastasis from
papillary adenocarcinoma of the thyroid gland. TTF-1 is
generally thought to be specific to the thyroid gland and
the lung.
Interestingly, several reports in recent years have oc-
casionally shown positive immunohistochemcial reactivity
for TTF-1 in adenocarcinomas with origins other than the
lung or the thyroid gland. One paper reported focal posi-
tivity for TTF-1 in 11 of 83 ovarian carcinomas and in 5 of 55
endometrial adenocarcinomas.3 Other reports described
TTF-1 expression in one of 20 colon adenocarcinomas
and one of 23 gastric adenocarcinomas.4 Based on thesefindings, TTF-1 staining for determining the primary origin
of the malignancy might be questionable despite these
different results being only sporadically reported.
As to nasopharyngeal papillary adenocarcinoma, one re-
cent report has demonstrated two primary nasopharyngeal
papillary adenocarcinomas also showing strong nuclear
expression for TTF-1.5 Therefore, we evaluated the immu-
nohistochemical staining with thyroglobulin and TTF-1 anti-
bodies for the patient. The results showed that the tumor
was negative for thyroglobulin, but displayed strong nuclear
expression for TTF-1. The etiology for positive TTF-1 staining
in primary nasopharyngeal papillary adenocarcinoma re-
mains unknown because the embryonic origins of the thyroid
gland and the nasopharynx are different and the naso-
pharynx rarely has aberrant thyroid tissue.
Accordingly, TTF-1 protein might not be a suitable
marker for distinguishing between metastatic or primary
nasopharyngeal papillary adenocarcinoma.
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